E
KLRS

Ergoteles’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Ergoteles’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-511
Closed -$60.3K – 1836
2022
Q4 		$60.3K Buy
+511
New +$60.3K ﹤0.01% 1278
2022
Q3 		– Sell
-1,235
Closed -$111K – 2065
2022
Q2 		$111K Buy
+1,235
New +$111K ﹤0.01% 1475